MiniMed Infusion From Medtronic Is November Tonic For Company's Stock
This article was originally published in The Gray Sheet
Medtronic's $30 mil. equity investment in infusion systems developer MiniMed in early November, which appears to set the stage for an outright acquisition, helped spark a 28.4% monthly price gain in MiniMed stock; the issue closed at 71-1/4, up 15-3/4.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.